Hologic, Mammotome, C.R. Bard Compete in Procedure Driven U.S. Breast Biopsy Market
According to a new series of reports on the female and neonatal diagnostic device market by iData Research (www.idataresearch.com), unit sales will continue to increase, driven primarily by the increasing average age of patients. As a person ages, the incidence of cancer or suspicious lesions that may require a biopsy increases. While other factors such as exposure to carcinogens, diet and level of physical activity also affect the rates of cancer, a patient's age is the most dominant driving force.
View full press release